142 related articles for article (PubMed ID: 12100798)
1. Management of uterine leiomyomata: what do we really know?
Myers ER; Barber MD; Gustilo-Ashby T; Couchman G; Matchar DB; McCrory DC
Obstet Gynecol; 2002 Jul; 100(1):8-17. PubMed ID: 12100798
[TBL] [Abstract][Full Text] [Related]
2. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
3. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
5. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
6. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids.
Talaulikar VS; Manyonda IT
Adv Ther; 2012 Aug; 29(8):655-63. PubMed ID: 22903240
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of mifepristone for the treatment of uterine leiomyomata.
Steinauer J; Pritts EA; Jackson R; Jacoby AF
Obstet Gynecol; 2004 Jun; 103(6):1331-6. PubMed ID: 15172874
[TBL] [Abstract][Full Text] [Related]
8. Uterine Leiomyomata in South Western Nigeria: a clinical study of presentations and management outcome.
Okogbo FO; Ezechi OC; Loto OM; Ezeobi PM
Afr Health Sci; 2011 Jun; 11(2):271-8. PubMed ID: 21857861
[TBL] [Abstract][Full Text] [Related]
9. Management of uterine fibroids.
al-Taher H; Farquharson RG
Br J Hosp Med; 1993 Jul 14-Aug 17; 50(2-3):133-6. PubMed ID: 8353665
[TBL] [Abstract][Full Text] [Related]
10. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy.
Wilkens J; Chwalisz K; Han C; Walker J; Cameron IT; Ingamells S; Lawrence AC; Lumsden MA; Hapangama D; Williams AR; Critchley HO
J Clin Endocrinol Metab; 2008 Dec; 93(12):4664-71. PubMed ID: 18765509
[TBL] [Abstract][Full Text] [Related]
11. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study.
Wise LA; Palmer JR; Stewart EA; Rosenberg L
Obstet Gynecol; 2005 Mar; 105(3):563-8. PubMed ID: 15738025
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology, presentation, and management of retroperitoneal leiomyomata: systematic literature review and case report.
Poliquin V; Victory R; Vilos GA
J Minim Invasive Gynecol; 2008; 15(2):152-60. PubMed ID: 18312983
[TBL] [Abstract][Full Text] [Related]
13. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations.
Sizzi O; Manganaro L; Rossetti A; Saldari M; Florio G; Loddo A; Zurawin R; van Herendael B; Djokovic D
Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():30-38. PubMed ID: 29149644
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.
Marshall LM; Spiegelman D; Goldman MB; Manson JE; Colditz GA; Barbieri RL; Stampfer MJ; Hunter DJ
Fertil Steril; 1998 Sep; 70(3):432-9. PubMed ID: 9757871
[TBL] [Abstract][Full Text] [Related]
15. Treatment of uterine leiomyomata: past, present and future.
Maheux R
Horm Res; 1989; 32 Suppl 1():125-33. PubMed ID: 2693323
[TBL] [Abstract][Full Text] [Related]
16. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
17. Hyalinization and cellular changes in uterine leiomyomata after gonadotropin releasing hormone agonist therapy.
Cohen D; Mazur MT; Jozefczyk MA; Badawy SZ
J Reprod Med; 1994 May; 39(5):377-80. PubMed ID: 7520497
[TBL] [Abstract][Full Text] [Related]
18. Uterine artery embolization as a treatment option for uterine myomas.
Marshburn PB; Matthews ML; Hurst BS
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
[TBL] [Abstract][Full Text] [Related]
19. Hysterectomy for the massive leiomyomatous uterus.
Unger JB; Paul R; Caldito G
Obstet Gynecol; 2002 Dec; 100(6):1271-5. PubMed ID: 12468173
[TBL] [Abstract][Full Text] [Related]
20. Pregnancies following treatment by GnRH-a (Decapeptyl) and myomectomy in infertile women with uterine leiomyomata.
Abramovici H; Dirnfeld M; Auslander R; Bornstein J; Blumenfeld Z; Sorokin Y
Int J Fertil Menopausal Stud; 1994; 39(3):150-5. PubMed ID: 7920751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
